• 1
    Brown RE, Bower MR, Martin RC. Hepatic resection for colorectal liver metastases. Surg Clin North Am. 2010;90:839-852.
  • 2
    Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005;12:637-645.
  • 3
    Venderbosch S, Wilt JH, Teerenstra S, et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol. 2011;18:3252-3260.
  • 4
    Karoui M, Roudot-Thoraval F, Mesli F, et al. Cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum. 2011;54:930-938.
  • 5
    Galizia G, Lieto E, Orditura M, et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg. 2008;143:352-358.
  • 6
    Benoist S, Pautrat K, Mitry E, et al. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005;92:1155-1160.
  • 7
    Ahmed S, Shahid RK, Pahwa P, et al. Survival benefit and complications of primary tumor resection (PTR) in patients with stage IV colorectal cancer (CRC) in the era of modern chemotherapy: A systematic review and meta-analysis. J Clin Oncol. 2013;31(suppl): abstract 3580.
  • 8
    Ahmed S, Shahid RK, Leis A, et al. Should noncurative resection of primary tumor be performed in patients with stage IV colorectal cancer? A systematic review and meta-analysis. Curr Oncol. 2013;20:e420-e441. doi:
  • 9
    Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379-3384.
  • 10
    McCahill LE, Yothers G, Sharif S, et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol. 2012 10;30:3223-3228.
  • 11
    Glimelius B, Cavalli-Björkman N. Metastatic colorectal cancer: current treatment and future options for improved survival. Medical approach-present status. Scand J Gastroenterol. 2012;47:296-314.
  • 12
    Faron M, Bourredjem A, Pignon J, et al. Impact on survival of primary tumor resection in patients with colorectal cancer and unresectable metastasis: Pooled analysis of individual patients' data from four randomized trials. J Clin Oncol. 2012;30(suppl): abstract 3507.
  • 13
    Vergote I, van Gorp T, Amant F, et al. Timing of debulking surgery in advanced ovarian cancer. Int J Gynecol Cancer. 2008;18(suppl 1):11-19.
  • 14
    Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet. 2001;358:966-970.
  • 15
    Merogi AJ, Ramesh R, Robinson WR, et al. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol. 1997;28:321-331.
  • 16
    Edler L, Heim ME, Quintero C. Prognostic factors of advanced colorectal cancer patients. Eur J Cancer Clin Oncol. 1986;22:1231-1237.
  • 17
    Köhne CH, Cunningham D, Di Costanzo F, et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol. 2002;13:308-317.
  • 18
    Connolly GC, Khorana AK, Kuderer NM, et al. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thrombosis Res. 2010;126:113-118.
  • 19
    Qiu MZ, Yuan ZY, Luo HY, et al. Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol. 2010;31:255-260.
  • 20
    Ferrand F, Malka D, Bourredjem A, et al. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601. Eur J Cancer. 2013;49:90-97.
  • 21
    Dutch Colorectal Cancer Group. CAIRO 4 trial. Accessed June 20, 2013.